Stocksigma LogoStocksigma Logo

Oxygenta Pharmaceutical Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

■ Revenue: 3,349 (+134.2% YoY | -9.5% QoQ) ■ EBITDA: 2.8 (Loss to Profit YoY | -94.8% QoQ) ■ EBITDA Margin (%): 0.1 (Loss to Profit YoY | -139 bps QoQ) ■

Oxygenta Pharmaceutical Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

Oxygenta Pharmaceutical Ltd · Outcome · 10 Nov 2026, 10:23 pm

Oxygenta Pharmaceutical Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 3,349 (+134.2% YoY | -9.5% QoQ) ■ EBITDA: 2.8 (Loss to Profit YoY | -94.8% QoQ) ■ EBITDA Margin (%): 0.1 (Loss to Profit YoY | -139 bps QoQ) ■ PAT: -274 (+44.5% YoY | -30.0% QoQ) ■ EPS (INR): -0.74 (+44.4% YoY | -29.8% QoQ)

Original exchange filing (PDF)

More announcements from Oxygenta Pharmaceutical Ltd

All Oxygenta Pharmaceutical Ltd announcements